These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 3390604)

  • 1. [Morphological study of the damaging effect of an EB vaccine strain of the plague microbe in inbred mice].
    Nazarova LS; Isupov IV; Pavlova LP; Gor'kova AV; Dushkin VA
    Biull Eksp Biol Med; 1988 Jun; 105(6):761-4. PubMed ID: 3390604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of Yersinia pestis antigens and strains on the level of lymphocyte blast transformation].
    Ledvanov MIu; Emel'ianova NV; Stukova NIu; Shvedun GP; Taranenko TM; Brandzishevskiĭ IuV
    Med Parazitol (Mosk); 1998; (4):25-7. PubMed ID: 10050549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Yersinia pestis lpxM-mutant live vaccine induces enhanced immunity against bubonic plague in mice and guinea pigs.
    Feodorova VA; Pan'kina LN; Savostina EP; Sayapina LV; Motin VL; Dentovskaya SV; Shaikhutdinova RZ; Ivanov SA; Lindner B; Kondakova AN; Bystrova OV; Kocharova NA; Senchenkova SN; Holst O; Pier GB; Knirel YA; Anisimov AP
    Vaccine; 2007 Nov; 25(44):7620-8. PubMed ID: 17913308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity.
    Eyles JE; Butcher WA; Titball RW; Hill J
    Vaccine; 2007 Oct; 25(42):7301-6. PubMed ID: 17869388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response.
    Montminy SW; Khan N; McGrath S; Walkowicz MJ; Sharp F; Conlon JE; Fukase K; Kusumoto S; Sweet C; Miyake K; Akira S; Cotter RJ; Goguen JD; Lien E
    Nat Immunol; 2006 Oct; 7(10):1066-73. PubMed ID: 16980981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stat 4 but not Stat 6 mediated immune mechanisms are essential in protection against plague.
    Elvin SJ; Williamson ED
    Microb Pathog; 2004 Oct; 37(4):177-84. PubMed ID: 15458778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An optimized vaccine vector based on recombinant vesicular stomatitis virus gives high-level, long-term protection against Yersinia pestis challenge.
    Palin A; Chattopadhyay A; Park S; Delmas G; Suresh R; Senina S; Perlin DS; Rose JK
    Vaccine; 2007 Jan; 25(4):741-50. PubMed ID: 16959385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.
    Zauberman A; Cohen S; Levy Y; Halperin G; Lazar S; Velan B; Shafferman A; Flashner Y; Mamroud E
    Vaccine; 2008 Mar; 26(13):1616-25. PubMed ID: 18304706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of the antibody neutralization reaction in differential diagnosis of the etiologic agent of plague and the study of mutual relations between the amount of fraction I and virulence in strains of the plague microbe (Pasteurella pestis).
    Timofeeva LA; Aparin GP
    J Hyg Epidemiol Microbiol Immunol; 1968; 12(4):420-5. PubMed ID: 5752128
    [No Abstract]   [Full Text] [Related]  

  • 10. [Behavior in vivo of strains of Pasteurella pestis in relation to their efficacy as live vaccines].
    Markenson J; Ben-Efraim S
    Ann Inst Pasteur (Paris); 1969 Aug; 117(2):196-212. PubMed ID: 5406056
    [No Abstract]   [Full Text] [Related]  

  • 11. [Study of PGM mutation mechanism in Yersinia pestis (plague pathogen) vaccine strain EV76].
    Podladchikova ON; Rykova VA; Ivanova VS; Eremenko NS; Lebedeva SA
    Mol Gen Mikrobiol Virusol; 2002; (2):14-9. PubMed ID: 12180018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective efficacy of a recombinant plague vaccine when co-administered with another sub-unit or live attenuated vaccine.
    Griffin K; Bedford R; Townson K; Phillpotts R; Funnell S; Morton M; Williamson D; Titball R
    FEMS Immunol Med Microbiol; 2005 Mar; 43(3):425-30. PubMed ID: 15708318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dam mutant of Yersinia pestis is attenuated and induces protection against plague.
    Robinson VL; Oyston PC; Titball RW
    FEMS Microbiol Lett; 2005 Nov; 252(2):251-6. PubMed ID: 16188402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague.
    Amemiya K; Meyers JL; Rogers TE; Fast RL; Bassett AD; Worsham PL; Powell BS; Norris SL; Krieg AM; Adamovicz JJ
    Vaccine; 2009 Apr; 27(16):2220-9. PubMed ID: 19428836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of the immune response to the (F1+V) vaccine in models of bubonic and pneumonic plague.
    Williamson ED; Stagg AJ; Eley SM; Taylor R; Green M; Jones SM; Titball RW
    Vaccine; 2007 Jan; 25(6):1142-8. PubMed ID: 17101198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague.
    Leary SE; Griffin KF; Garmory HS; Williamson ED; Titball RW
    Microb Pathog; 1997 Sep; 23(3):167-79. PubMed ID: 9281474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study in mice of the protective power of the EV strain of Yersinia pestis and of its culture supernatant].
    Fournier JM; Creach O; Chaboud JJ; Dodin A; Fontanges R
    C R Acad Hebd Seances Acad Sci D; 1972 Dec; 275(25):3057-9. PubMed ID: 4631979
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the variability of the plague vaccinal strain EB].
    Zhurba MD; Priadkina MD; Abramova GF
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Apr; 43(4):64-7. PubMed ID: 6004746
    [No Abstract]   [Full Text] [Related]  

  • 19. Plague immunization. II. Relation of adverse clinical reactions to multiple immunizations with killed vaccine.
    Marshall JD; Bartelloni PJ; Cavanaugh DC; Kadull PJ; Meyer KF
    J Infect Dis; 1974 May; 129():Suppl:S19-25. PubMed ID: 4596517
    [No Abstract]   [Full Text] [Related]  

  • 20. [On pathogenetic significance of activation of lipid peroxidation in the mechanisms of disturbance of blood rheologic properties in experimental intoxication induced by fraction FII of vaccinal EV strain of Y. pestis].
    Afanas'eva GA; Chesnokova NP
    Vestn Ross Akad Med Nauk; 2009; (2):14-8. PubMed ID: 19280983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.